Ex vivo perfusion-based engraftment of genetically engineered cell sensors into transplantable organs

PLoS One. 2019 Dec 2;14(12):e0225222. doi: 10.1371/journal.pone.0225222. eCollection 2019.

Abstract

Cellular rejection of liver transplant allografts remains a concern despite immunosuppressant use. Existing transplant biomarkers are often not sensitive enough to detect acute or chronic rejection at an early enough stage to allow successful clinical intervention. We herein developed a cell-based sensor that can potentially be used for monitoring local events following liver transplantation. Utilizing a machine perfusion system as a platform to engraft the cells into a donor liver, we effectively established the biocompatibility of the biosensor cells and confirmed efficient delivery of cells distributed throughout the organ. This work proves an innovative concept of integrating synthetic reporter cells ex vivo into organs as a transplant-within-a-transplant during functional organ preservation with a vision to use cell biosensors as a broad way to monitor and treat tissue transplants.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Engineering / methods*
  • Cell Line
  • Cell- and Tissue-Based Therapy / methods*
  • Fibroblasts*
  • Genetic Engineering / methods*
  • Genetic Vectors
  • Graft Rejection / prevention & control
  • Liver Transplantation / methods*
  • Living Donors
  • Male
  • Perfusion / methods*
  • Rats
  • Rats, Inbred Lew
  • Transplants*